Compounds > activins

activins and Mucocutaneous Lymph Node Syndrome

activins has been researched along with Mucocutaneous Lymph Node Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Huang, Y; Wang, L; Weng, R; Wu, Q; Xu, Y; Yang, J1
Huang, Y; Wang, L; Weng, R; Wu, Q; Yang, J; Yang, Z1

Other Studies

2 other study(ies) available for activins and Mucocutaneous Lymph Node Syndrome

ArticleYear
Activin a suppresses peripheral CD8
    BMC immunology, 2021, 02-23, Volume: 22, Issue:1

    Topics: Activin Receptors, Type II; Activins; Antigens, CD; Antigens, CD19; Antigens, Differentiation, T-Lymphocyte; CD8-Positive T-Lymphocytes; Child, Preschool; Female; Humans; Infant; Interleukin-2 Receptor alpha Subunit; Lectins, C-Type; Lymphocyte Activation; Lymphocyte Count; Lymphocyte Subsets; Male; Mucocutaneous Lymph Node Syndrome

2021
Effect of Activin A on activation status of monocytes in acute-phase Kawasaki disease.
    Clinical and experimental medicine, 2021, Volume: 21, Issue:3

    Topics: Activin Receptors, Type I; Activin Receptors, Type II; Activins; B7-1 Antigen; B7-2 Antigen; Down-Regulation; Humans; Interleukin-1beta; Monocytes; Mucocutaneous Lymph Node Syndrome; Signal Transduction; Tumor Necrosis Factor-alpha

2021